CSU logo TB Vaccine Testing and Research Materials Contract
Home
Vaccine Testing
Research Materials
  Materials Available
 
Links
Contacts
Frequently Asked Questions
Publications
BEI Resources Transition

Attention

Research materials produced by the TBVTRM Contract are distributed by the Biodefense and Emerging Infections Research Resources Repository (BEI Resources). Please visit our page on the BEI Resources website for complete ordering instructions:
http://www.beiresources.org/TBVTRMResearchMaterials/tabid/1431/Default.aspx .

45 kDa Glycoprotein

Reagent:
Rv1860, 45 kDa glycoprotein, MPT32, ModD, Apa

Default Quantity:
500 µg

Production system:
CFPs are precipitated with a 40% saturated solution of ammonium sulfate. The precipitate is suspended and incubated with Conconavalin-A resin, and the 45 kDa is eluted with alpha-methyl mannoside. This fraction is concentrated and dialyzed. A final purification is performed using hydrophobic interaction (phenyl sepharose) HPLC. The purified 45 kDa glycoprotein is lyophilized and stored at -80°C.

Notes:
The 45 kDa glycoprotein appears as a doublet by SDS-PAGE. The major component is 45 kDa and the minor component is a 42 kDa degradation product. The mature MPT 32 glycoprotein has a calculated molecular weight of 30.2 kDa, however the abundance of proline residues along with glycosylation causes this molecule to migrate at 45 kDa by SDS-PAGE.

References:
Dobos K.M. et al., Infect. Immun. 63:2846, 1995.
Dobos K.M. et al., J. Bact. 178:2498, 1996.

 

Return to Native Proteins | Return to Materials Available